Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

U.K. (FTSE) Pharma Industry Analysis

UpdatedMay 17, 2025
DataAggregated Company Financials
Companies16
  • 7D0.7%
  • 3M-7.8%
  • 1Y-12.6%
  • YTD-0.5%

In the last week, Pharma has been flat. As for the longer term, the industry has declined 13% in the last year. Earnings are forecast to grow by 14% annually.

Industry Valuation and Performance

Has the U.K. Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 17 May 2025UK£259.8bUK£87.2bUK£10.7b26.3x24.2x3x
Mon, 14 Apr 2025UK£247.9bUK£87.2bUK£9.7b28.8x25.7x2.8x
Wed, 12 Mar 2025UK£283.5bUK£87.7bUK£9.6b28.9x29.5x3.2x
Fri, 07 Feb 2025UK£285.3bUK£87.1bUK£9.1b31.7x31.3x3.3x
Sun, 05 Jan 2025UK£226.4bUK£75.8bUK£7.8b31.4x28.9x3x
Tue, 03 Dec 2024UK£225.9bUK£75.1bUK£7.7b31.8x29.2x3x
Thu, 31 Oct 2024UK£238.7bUK£72.5bUK£9.1b30.5x26.3x3.3x
Sat, 28 Sep 2024UK£250.9bUK£71.3bUK£8.9b30.5x28.1x3.5x
Mon, 26 Aug 2024UK£275.7bUK£71.8bUK£8.9b41.6x30.8x3.8x
Wed, 24 Jul 2024UK£258.1bUK£70.9bUK£9.5b35.4x27.3x3.6x
Fri, 21 Jun 2024UK£266.0bUK£71.7bUK£9.6b30x27.8x3.7x
Sun, 19 May 2024UK£268.2bUK£71.5bUK£9.6b34.9x28x3.7x
Tue, 16 Apr 2024UK£247.5bUK£71.4bUK£9.8b33x25.3x3.5x
Thu, 14 Mar 2024UK£240.5bUK£70.2bUK£9.7b33.1x24.8x3.4x
Sat, 10 Feb 2024UK£225.8bUK£69.7bUK£9.6b34.8x23.5x3.2x
Mon, 08 Jan 2024UK£241.2bUK£68.9bUK£10.7b36x22.6x3.5x
Wed, 06 Dec 2023UK£227.5bUK£69.3bUK£10.7b34.3x21.2x3.3x
Fri, 03 Nov 2023UK£231.4bUK£70.9bUK£11.0b52.6x21x3.3x
Sun, 01 Oct 2023UK£247.2bUK£70.5bUK£10.4b76.3x23.8x3.5x
Tue, 29 Aug 2023UK£235.2bUK£69.4bUK£10.2b53.5x23x3.4x
Thu, 27 Jul 2023UK£235.9bUK£67.1bUK£7.8b52x30.2x3.5x
Sat, 24 Jun 2023UK£248.0bUK£67.8bUK£7.9b55.5x31.5x3.7x
Mon, 22 May 2023UK£257.1bUK£68.6bUK£8.0b56.6x32.3x3.7x
Wed, 19 Apr 2023UK£260.2bUK£69.3bUK£6.9b57.6x37.9x3.8x
Fri, 17 Mar 2023UK£235.2bUK£70.2bUK£6.9b44.3x33.9x3.3x
Sun, 12 Feb 2023UK£249.4bUK£70.4bUK£7.4b40.8x33.8x3.5x
Tue, 10 Jan 2023UK£252.5bUK£79.7bUK£6.3b39.2x40x3.2x
Thu, 08 Dec 2022UK£246.8bUK£79.8bUK£6.3b36.5x39x3.1x
Sat, 05 Nov 2022UK£235.4bUK£80.7bUK£3.7b20.1x64.1x2.9x
Mon, 03 Oct 2022UK£217.5bUK£81.3bUK£3.6b19.5x59.6x2.7x
Wed, 31 Aug 2022UK£238.9bUK£79.3bUK£3.7b14.1x64.1x3x
Fri, 29 Jul 2022UK£254.2bUK£75.1bUK£4.6b15.2x55.6x3.4x
Sun, 26 Jun 2022UK£268.8bUK£74.3bUK£4.6b16.8x58.8x3.6x
Tue, 24 May 2022UK£267.5bUK£73.5bUK£4.6b17.4x58.4x3.6x
Price to Earnings Ratio

58.4x


Total Market Cap: UK£267.5bTotal Earnings: UK£4.6bTotal Revenue: UK£73.5bTotal Market Cap vs Earnings and Revenue0%0%0%
U.K. Pharma Industry Price to Earnings3Y Average 35.3x202320242025
Current Industry PE
  • Investors are pessimistic on the British Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 24.2x which is lower than its 3-year average PE of 35.3x.
  • The 3-year average PS ratio of 3.4x is higher than the industry's current PS ratio of 3.0x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have grown 33% per year over the last three years.
  • Revenues for these companies have grown 5.9% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the U.K. Healthcare industry?

GB Market1.61%
Healthcare0.84%
Pharma0.69%
Pharma0.69%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
AZN AstraZenecaUK£103.300.9%
+UK£1.4b		-14.7%PE27.4x
GSK GSKUK£13.951.2%
+UK£659.6m		-21.4%PE18x
HIK Hikma PharmaceuticalsUK£20.703.3%
+UK£145.5m		4.7%PE16.9x
INDV IndiviorUK£8.452.0%
+UK£20.6m		-36.8%PS1.2x
AGY Allergy TherapeuticsUK£0.0722.1%
+UK£7.1m		123.1%PS6.2x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlans & PricingLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & EnterpriseWhat's New
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

HCM

UK£2.05

HUTCHMED (China)

7D

-10.1%

1Y

-36.7%

HIK

UK£20.70

Hikma Pharmaceuticals

7D

3.3%

1Y

4.7%

GSK

UK£13.95

GSK

7D

1.2%

1Y

-21.4%

AZN

UK£103.30

AstraZeneca

7D

0.9%

1Y

-14.7%

INDV

UK£8.45

Indivior

7D

2.0%

1Y

-36.8%

HLN

UK£4.04

Haleon

7D

-0.7%

1Y

22.8%

Here's Why Haleon (LON:HLN) Can Manage Its Debt Responsibly

May 10
Here's Why Haleon (LON:HLN) Can Manage Its Debt Responsibly

AGY

UK£0.072

Allergy Therapeutics

7D

2.1%

1Y

123.1%

Investors Appear Satisfied With Allergy Therapeutics plc's (LON:AGY) Prospects As Shares Rocket 26%

May 09
Investors Appear Satisfied With Allergy Therapeutics plc's (LON:AGY) Prospects As Shares Rocket 26%

NFX

UK£0.0013

Nuformix

7D

-3.8%

1Y

-32.4%

ANCR

UK£2.45

Animalcare Group

7D

0.8%

1Y

7.0%

STX

UK£0.024

Shield Therapeutics

7D

-2.1%

1Y

34.3%

IMM

UK£0.034

ImmuPharma

7D

7.4%

1Y

39.5%

N4P

UK£0.0047

N4 Pharma

7D

-9.5%

1Y

-40.6%

FUM

UK£0.093

Futura Medical

7D

6.6%

1Y

-76.7%

INC

UK£0.055

Incanthera

7D

-4.3%

1Y

-71.1%

SAR

UK£0.16

Sareum Holdings

7D

-8.6%

1Y

-52.9%

ANA

UK£0.0032

Ananda Pharma

7D

-13.3%

1Y

30.0%